Topics:

Schizophrenia

Treating Comorbid Anxiety With Schizophrenia

Identifying comorbid anxiety disorders as potential treatment targets may contribute to more positive outcomes for patients with schizophrenia.

Related content:
Mini Quiz: Antipsychotic Metabolic Effects

Schizophrenia

Phenomenology in an Acute Care Setting

We present the case of a patient for whom different attending providers had markedly different interpretations. As the case unfolds, we invite you to reflect on your diagnostic understanding of each presentation.

Metabolic syndrome may be a particularly important marker of antipsychotic metabolic effects.

Identifying comorbid anxiety disorders as potential treatment targets may contribute to more positive outcomes for patients with schizophrenia. Details here.

The psychiatrist’s role is to act as a consultant to maximize the likelihood of a successful taper and discontinuation and to minimize collateral morbidities or withdrawal complications. This slideshow features common scenarios in which a planned discontinuation of psychotropic medications occurs.

A CME covering contemporary ideas about psychotic conditions and clinical approaches for treatment.

This article focuses on auditory hallucinations, which occur in a range of psychiatric and medical disorders as well as in individuals without mental illness.

The authors review the evidence for the use of ECT and other novel neurostimulation techniques in the treatment of schizophrenia.

Pages

Subscribe to Schizophrenia on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.